NorthWest Biotherapeutics Inc (NWBO)

[Ready4bluesky]

It seems there are too many unknown variables at this time to complete this exercise. For instance; the final cost of treatment, the reimbursement amount that would be approved by insurance on multiple continents and the timing of such approvals, royalties?, market penetration, final share count at time of approval (Branko's is understated IMO) just to name a few. If L were to receive FDA AA, my estimate is an initial jump up to somewhere in the $15-$30 range. The probability of a short squeeze is extremely low IMO. My assumption is that the short positions are well hedged.